Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-09-05

Clinical Trial Update: Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether sodium bicarbonate solution lowers the incidence of contrast-induced nephropathy. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Bicarbonate Solution (sodium bicarbonate)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Contrast Induced Nephropathy | Phase 3 | Status: COMPLETED